top of page

Eyes on Pharma
Check-out What Intel Caught our Eye

Jana Chisholm
Dec 11, 202416 min read
Eyes on 3Q24 Financial Results
We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.


Jana Chisholm
Nov 17, 20244 min read
Eyes on Sanofi, Regeneron, Novo Nordisk, and Pfizer
We've had Eyes On some of the recent deals, results, and investor actions. Check out the happenings at Sanofi/Opella, Pfizer, Regeneron, and

Jana Chisholm
Oct 5, 20246 min read
Eyes on BMS, Pfizer, & Amgen
Eye's on the Amgen data releases for gMG & Atopic Dermatitis, the BMS approval of Cobenfy for schizophrenia, and Pfizer's Oxbryta recall...

Jana Chisholm
Jul 17, 20245 min read
Eyes On the Competition
his week we've been looking at the competition heating up due to a combination of M&A, biosimilar entrants, and new clinical data ...

Jana Chisholm
Jul 7, 20245 min read
Eyes on Oncology, Anti-Virals, and Consumer Products
We've had our Eyes On recent data releases, commercial strategy updates, and some FDA updates. What caught your Eye last week?

Jana Chisholm
Jun 18, 20243 min read
Eyes on ASCO 2024
The ASCO 2024 annual meeting took place from 31st May to 4th June. A number of firms presented data, and others used this as an opportunity

jroele
Jun 7, 20242 min read
Our Comments & Links on Top 4 Biggest Drugs in 2023
Check out this Top Drugs of 2023 list with links to interesting reports in PharmaTell Studio. Contact us for a trial.

Jana Chisholm
May 2, 20244 min read
1Q24 BioPharma Deals & Raises
We've been keeping Eyes On Deals & Raises in the BioPharma sector for the first quarter of 2024. Things seem to be heating-up ...

Jana Chisholm
Apr 16, 20243 min read
Eyes on Corporate Restructuring
Lately we've been keeping Eyes On the corporate restructuring in the BioPharma sector. We've seen Big Pharma and BioTech refocusing ...

Jana Chisholm
Mar 24, 20244 min read
Eyes on Current Events - Deals, Approvals & Operations
We've been trying to keep up with current events - here's some of what we've hay Eyes On this week.

Jana Chisholm
Jan 10, 20247 min read
Eyes on Genetic Medicines & Pipelines
Following up on our previous post about Gene Therapies, we are sharing data on Genetic Medicines in development - pipelines, targets, dates


Jana Chisholm
Dec 1, 20233 min read
Eyes on Clinical Trial Data, Supply Upgrades, and Patent Litigation
The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and


Robin Bateman
Feb 27, 20222 min read
Opioids, SPACs, Top 10 Lists, and more Results
Check out the latest on some of the Opioid Litigation, SPACS, and yes two Top 10 Lists!


Robin Bateman
Feb 22, 20222 min read
R&D Trends, ASCO-GU, & Earnings
The Eyes on Pharma team was caught up in reviewing global R&D trends and following the updates from ASCO-GU ...
bottom of page